Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma, Neuroendocrine × Leucovorin × Endocrine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 4 Vipoma 3 Somatostatinoma 3 Insulinoma 3 Glucagonoma 3 Gastrinoma 3 Carcinoma, Islet Cell 3 Neuroendocrine Tumors 2 Adenoma, Islet Cell 2 Stomach Neoplasms 1 Pseudomyxoma Peritonei 1 Pheochromocytoma 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasms, Unknown Primary 1 Lung Neoplasms 1 Gastrointestinal Stromal Tumors 1 Gastro-enteropancreatic neuroendocrine tumor 1 Gallbladder Neoplasms 1 Fallopian Tube Neoplasms 1 Colonic Neoplasms 1 Carcinoma, Neuroendocrine 1 Carcinoma, Hepatocellular 1 Bile Duct Neoplasms 1 Appendiceal Neoplasms 1

Interventions

Cisplatin 11 Everolimus 10 Nivolumab 7 Etoposide 7 Temozolomide 5 Ipilimumab 5 Carboplatin 5 atezolizumab 4 Irinotecan 4 pembrolizumab 3 lutetium Lu 177 dotatate 3 avelumab 3 Paclitaxel 3 Fluorouracil 3 Capecitabine 3 Bevacizumab 3 surufatinib 2 sintilimab 2 dostarlimab 2 belinostat 2 azaspirane 2 Topotecan 2 Positron Emission Tomography Computed Tomography 2 Magnetic Resonance Imaging 2 Immunoglobulin G 2 IFL protocol 2 Fluorodeoxyglucose F18 2 EC regimen 2 Drug Therapy 2 Disulfides 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03837977 2024-12-30

NET02

The Christie NHS Foundation Trust

Phase 2 Completed

Neoplasms, Carcinoma, Neuroendocrine

Data powered by HemOnc (CC BY 4.0) Colophon ⚡